» Articles » PMID: 30581341

Important Biomarkers That Play a Role in the Chronic Obstructive Pulmonary Disease Process

Overview
Journal J Med Biochem
Specialty Biochemistry
Date 2018 Dec 25
PMID 30581341
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic obstructive pulmonary disease (COPD) that includes multiple mechanisms such as inflammation, infection, smoking, hypoxia, and lack of antioxidant response can cause oxidative stress. In our study, we aimed to determine the changes in some oxidative stress [malondialdehyde and glutathione] and some cellular immunity markers (neopterin and TGF-b) in patients diagnosed with COPD and determine the damage to the organism.

Methods: While the high-performance liquid chromatography (HPLC) method (Immuchrom kit, Germany) was utilized to determine MDA, GSH and NP levels, the ELISA method was used for TGF-b levels.

Results: All obtained data regarding each parameter were compared with both COPD and healthy individuals and between parameters. There was a statistically significant difference between the control group of healthy subjects and COPD group in all parameters (p<0.05). A negative and correlation between oxidant MDA and antioxidant GSH parameters was determined (p=-0.394).

Conclusions: As a result, it was seen that oxidative balance changed in the patient group and cellular immunity increased. When the obtained data and literature are taken into account, these changes occurring in oxidative balance and cellular immunity are of importance in determining the development in the pathogenesis of COPD, treatment op - tions and their risks for heart disease in advance.

Citing Articles

Effects of doxofylline as an adjuvant on severe exacerbation and long-term prognosis for COPD with different clinical subtypes.

Chen M, He W, Huang D, Jia H, Zhong Z, Li N Clin Respir J. 2023; 17(9):851-864.

PMID: 37562435 PMC: 10500324. DOI: 10.1111/crj.13670.


Reactive Oxygen Species and Antioxidative Defense in Chronic Obstructive Pulmonary Disease.

Taniguchi A, Tsuge M, Miyahara N, Tsukahara H Antioxidants (Basel). 2021; 10(10).

PMID: 34679673 PMC: 8533053. DOI: 10.3390/antiox10101537.


Procalcitonin kinetics to guide sequential invasive-noninvasive mechanical ventilation weaning in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: procalcitonin's adjunct role.

Lin S, He Y, Lian J, Chu C Libyan J Med. 2021; 16(1):1961382.

PMID: 34357857 PMC: 8354150. DOI: 10.1080/19932820.2021.1961382.


Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion.

Kim M, Baumlin N, Dennis J, Yoshida M, Kis A, Aguiar C ERJ Open Res. 2021; 7(1).

PMID: 33532463 PMC: 7836504. DOI: 10.1183/23120541.00394-2020.


Reliability and Usefulness of Different Biomarkers of Oxidative Stress in Chronic Obstructive Pulmonary Disease.

Zinellu E, Zinellu A, Fois A, Fois S, Piras B, Carru C Oxid Med Cell Longev. 2020; 2020:4982324.

PMID: 32509143 PMC: 7244946. DOI: 10.1155/2020/4982324.


References
1.
Ursavas A, Karadag M, Oral A, Demirdogen E, Oral H, Ege E . Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med. 2008; 102(8):1193-7. DOI: 10.1016/j.rmed.2008.02.019. View

2.
Barnes P, Karin M . Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336(15):1066-71. DOI: 10.1056/NEJM199704103361506. View

3.
Koca T, Berber A, Koca H, Demir T, Koken T . Effects of hemodialysis period on levels of blood trace elements and oxidative stress. Clin Exp Nephrol. 2010; 14(5):463-8. DOI: 10.1007/s10157-010-0310-3. View

4.
Wirleitner B, Baier-Bitterlich G, Hoffmann G, Schobersberger W, Wachter H, Fuchs D . Neopterin derivatives to activate NF-kappa B. Free Radic Biol Med. 1997; 23(1):177-9. DOI: 10.1016/s0891-5849(96)00632-6. View

5.
Cakir E, Akgul O, Aydin I, Cayci T, Kurt Y, Onguru O . The association between neopterin and acetaminophen-induced nephrotoxicity. Ren Fail. 2010; 32(6):740-6. DOI: 10.3109/0886022X.2010.486500. View